(Q42845531)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Correlation between imatinib pharmacokinetics and clinical response in Japanese patients with chronic-phase chronic myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

main subject

chronic myeloid leukemia

0 references

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

N Takahashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

H Wakita

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Miura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

K Nishii

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Masuko

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Sakai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Y Maeda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

K Ishige

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Kashimura

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

K Fujikawa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Fukazawa

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

T Katayama

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

F Monma

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Narita

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

F Urase

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

T Furukawa

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Y Miyazaki

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

N Katayama

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

K Sawada

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

27 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

809-813

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Imatinib mesylate in the treatment of gastrointestinal stromal tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Clinical resistance to imatinib: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Clinical pharmacokinetics of imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Fluorescence in situ hybridization monitoring of BCR-ABL-positive neutrophils in chronic-phase chronic myeloid leukemia patients during the primary stage of imatinib mesylate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.186

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2010.186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980997%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference